FADD overexpression	Squamous Cell Carcinoma of Head and Neck	FADD overexpression	Squamous Cell Carcinoma of Head and Neck	IGM-9427 Sensitive: D – Preclinical IGM-9427 Sensitive : D	IGM-9427 Sensitive: D – Preclinical IGM-9427 Sensitive : D
FADD overexpression + BIRC2 overexpression	Squamous Cell Carcinoma of Head and Neck	FADD overexpression + BIRC2 overexpression	Squamous Cell Carcinoma of Head and Neck	IGM-9427 Sensitive: D – Preclinical IGM-9427 Sensitive : D	IGM-9427 Sensitive: D – Preclinical IGM-9427 Sensitive : D
FADD amplification	Squamous Cell Carcinoma of Head and Neck	FADD amplification	Squamous Cell Carcinoma of Head and Neck	IGM-9427 Sensitive: D – Preclinical IGM-9427 Sensitive : D	IGM-9427 Sensitive: D – Preclinical IGM-9427 Sensitive : D
FADD amplification + BIRC2 amplification	Squamous Cell Carcinoma of Head and Neck	FADD amplification + BIRC2 amplification	Squamous Cell Carcinoma of Head and Neck	IGM-9427 Sensitive: D – Preclinical IGM-9427 Sensitive : D	IGM-9427 Sensitive: D – Preclinical IGM-9427 Sensitive : D
RB1 deletion	Estrogen Receptor Positive Breast Cancer	RB1 deletion	Estrogen Receptor Positive Breast Cancer	IGM-9427 Sensitive: D – Preclinical IGM-9427 Sensitive : D	IGM-9427 Sensitive: D – Preclinical IGM-9427 Sensitive : D

birinapant (IGM-9427)

Associations
(5)